BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37881428)

  • 21. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 2-(isoxazol-5-yl)phenyl 3,4-dihydroxybenzoate as a potential inhibitor for the Wnt/β-catenin pathway.
    Dong Y; Liu M; Mao Y; Wu S; Wen J; Lu J; Yang Y; Ruan S; Li L; Liu X; Zhang J; Liao S; Dong L
    Bioorg Chem; 2022 Nov; 128():106116. PubMed ID: 36063753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMEK1 promotes lung adenocarcinoma proliferation and invasion by activating Wnt/β-catenin signaling pathway.
    Chen D; Gao S; Gao F; Liu A; Li J; Li J; Liu Q
    Clin Transl Oncol; 2023 Apr; 25(4):976-986. PubMed ID: 36463369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
    Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
    Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.
    Hou S; Tian T; Qi D; Sun K; Yuan Q; Wang Z; Qin Z; Wu Z; Chen Z; Zhang J
    Cell Death Dis; 2018 Feb; 9(3):277. PubMed ID: 29449540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway.
    Wang Z; Fang Z; Chen G; Liu B; Xu J; Li F; Li F; Liu H; Zhang H; Sun Y; Tian G; Chen H; Xu G; Zhang L; Hu L; Ji H
    Neoplasia; 2021 Feb; 23(2):222-233. PubMed ID: 33387960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
    Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
    Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
    J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Luo W; Zhang Y; Ji H
    J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
    Guo YZ; Xie XL; Fu J; Xing GL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs.
    Jiang HL; Jiang LM; Han WD
    J BUON; 2015; 20(4):1094-100. PubMed ID: 26416062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-density lipoprotein receptor-related protein 8 facilitates the proliferation and invasion of non-small cell lung cancer cells by regulating the Wnt/β-catenin signaling pathway.
    Fang Z; Zhong M; Zhou L; Le Y; Wang H; Fang Z
    Bioengineered; 2022 Mar; 13(3):6807-6818. PubMed ID: 35246020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
    Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
    Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.
    Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q
    Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of Wnt/β-catenin Pathway Elevates the Sensitivity of Gastric Cancer Cells to PD-1 Antibody.
    Li J; Zhang H; Bei S; Zhang X; Li H; Ye L; Feng L
    Curr Mol Pharmacol; 2022; 15(3):557-569. PubMed ID: 34139974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.